Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • CSM Announces Partnership With IMP to Deliver Clinical Trial Supply Services Globally

    Mar 9, 2016, 10:10 AM by Michael Croft
    TEL AVIV, ISRAEL - Mar 9, 2016 - CSM has announced its global partnership with IMP, unifying their clinical trial supply services for pharmaceutical and biotechnology companies worldwide
    Full story
  • Clinical Research Services Provider Clintrax Global Joins WIRB-Copernicus Group

    Mar 9, 2016, 09:19 AM by Michael Croft
    PRINCETON, NJ - Mar 9, 2016 - WIRB-Copernicus Group® (WCG™), one of the world's leading providers of solutions that measurably improve the quality and efficiency of clinical research, today announced that Clintrax Global has joined its family of companies
    Full story
  • Definiens Launches Immunoprofiling Panel to Rapidly Screen Tissue Samples for Immune Responses

    Mar 8, 2016, 10:20 AM by Michael Croft
    MUNICH, UNITED STATES - Mar 8, 2016 - Definiens, the pioneer in Tissue Phenomics solutions for diagnostics development and commercialization, today announced the release of a new service, the Immunoprofiling Panel, to enable pharmaceutical companies, companion diagnostic developers and academic research centers working in immuno-oncology to quickly screen their target biomarkers and measure immune response
    Full story
  • SeraCare Launches Circulating Tumor DNA Reference Materials for NGS and Digital PCR-based Oncology Assays

    Mar 7, 2016, 17:00 PM by Michael Croft
    MILFORD, MA - Mar 7, 2016 - SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers, today announces the launch of two new circulating tumor DNA (ctDNA)  products at the 2016 Molecular Medicine Tri-Conference in San Francisco
    Full story
  • Changes at Illumina for Flatley, deSouza, Kahn

    Mar 7, 2016, 17:00 PM by Michael Croft
    Bio-IT World Brief | Changes at Illumina this week. Today Jay Flatley, current Chairman and CEO, announced he will assume the role of Executive Chairman of the Board of Directors on July 5, 2016. Francis deSouza, currently President, will be appointed President and Chief Executive Officer on the same date and will continue to serve on the Illumina Board of Directors. Scott Khan, Illumina’s Vice President Commercial, Enterprise Informatics, has said he plans to retire from Illumina in early March as well.
    Full story
  • NuGEN Technologies Launches “Sharing Experiences and Applications in Science” (SEAS) Institute

    Mar 7, 2016, 12:44 PM by Michael Croft
    SAN CARLOS, CA, UNITED STATES - Mar 7, 2016 - NuGEN Technologies, Inc. today announced the launch of the "Sharing Experiences and Applications in Sciences" (SEAS) Institute, the company's platform for supporting and spotlighting the work of innovative scientists
    Full story
  • Scientist at MDI Biological Laboratory Identifies Mechanism to Regenerate Heart Tissue

    Mar 7, 2016, 11:32 AM by Michael Croft
    BAR HARBOR, ME, USA - Mar 7, 2016 - The MDI Biological Laboratory has announced new discoveries about the mechanisms underlying the regeneration of heart tissue by Assistant Professor Voot P
    Full story
  • Rho Supports Follow-up Study Demonstrating Benefit of Early Peanut Consumption is Maintained Following One Year of Peanut Avoidance

    Mar 4, 2016, 15:19 PM by Michael Croft
    CHAPEL HILL, NC, UNITED STATES - Mar 4, 2016 - Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, is part of a newly published clinical trial that found that children who consumed peanut-containing foods regularly from infancy to age five and then avoided peanut for one year did not become allergic to peanut
    Full story
  • PrecisionFDA Consistency Challenge Will Benchmark the Basic Software Tools of Genetic Research

    Mar 4, 2016, 10:30 AM by Michael Croft
    Bio-IT World | The first challenge hosted in the FDA's cloud-based precisionFDA platform will score different computational pipelines' ability to accurately call variants from raw DNA sequence data, in a public competition meant to shed light on some of the most essential tools in genomics.
    Full story
  • Rare disease or rare success: a tale of two genomes

    Mar 4, 2016, 05:39 AM by Michael Croft
    CAMBRIDGE, UK - Mar 4, 2016 - When Congenica heard how an Iowa woman with a severe muscle wasting disease had not only diagnosed the genetic basis of her condition, but also realised it was linked it to a muscle-bound phenotype exhibited by Canadian Olympic hurdler Priscilla Lopes-Schliep, the company was inspired and wanted to see if they could help
    Full story
  • Husson University to Launch MBA with a Concentration in Biotechnology and Innovation in Fall 2016

    Mar 3, 2016, 20:02 PM by Michael Croft
    BANGOR, ME, UNITED STATES - Mar 4, 2016 - Husson University announced today that it is launching six new programs in science, technology and management designed to prepare students for career success in current and emerging fields
    Full story
  • Omicia Announces Appointment of Matt Tindall as Chief Executive Officer

    Mar 3, 2016, 14:40 PM by Michael Croft
    OAKLAND, CA - Mar 3, 2016 - Omicia, the leading provider of clinical genome interpretation software and services, announced that Matt Tindall has been appointed CEO and a member of the company’s Board of Directors, effective March 1st, 2016
    Full story
  • Alaska’s Biotech Sugar Daddy Is Showering Money on Startups

    Mar 3, 2016, 11:20 AM by Michael Croft
    Bloomberg.com | Alaska's economic eminence stems from the discovery of oil on the North Slope in the 1960s. But its more recent crown as a biotech sugar daddy started in March 2013 with a chance meeting on a flight from Boston to Seattle.
    Full story
  • OCF delivers new 181 Teraflop HPC resource for University College London

    Mar 2, 2016, 12:05 PM by Michael Croft
    LONDON, UNITED KINGDOM - Mar 2, 2016 -
    • UCL's new 'GRACE' machine to benefit researchers from across the University
    • Large scale parallel computing returns to the University
    • Designed and integrated by OCF
    • Linpack benchmark conducted by OCF delivered 181x
    Full story
  • Precision for Medicine Transforms Big Data Into Actionable Information

    Mar 2, 2016, 11:35 AM by Michael Croft
    Bio-IT World | Precision for Medicine will formally launch its immuno-analytics platform solution this month, the latest addition to its PATH suite of tools for contending with big 'omics data even when working with small sample sizes.
    Full story
  • BC Platforms and Microsoft to Provide Expanded Genomic Data Management Solutions in the Cloud

    Mar 2, 2016, 03:46 AM by Michael Croft
    BASEL, SWITZERLAND - Mar 2, 2016 - BC Platforms, a world leader in genomic data management solutions, today announced that it will collaborate with Microsoft to use the Microsoft Azure cloud platform and services to provide integrated genomic data management solutions in healthcare
    Full story
  • MAVERIX BIOMICS Offers Free Trial of Self-Service RNA-Seq Data Analysis for Next Generation Sequencing (NGS) Datasets

    Mar 1, 2016, 10:35 AM by Michael Croft
    SAN MATEO - Mar 1, 2016 - Maverix Biomics, a leading Next Generation Sequencing (NGS) data analysis software company, today made available a free 30-day trial of the Maverix WAVES™ RNA-Seq Gene Expression Analysis solution
    Full story
  • February News and Product Briefs

    Mar 1, 2016, 10:30 AM by Michael Croft
    Bio-IT World | The latest products and announcements from around the industry, including the introduction of Arvados to Microsoft Azure, and an online solution for metagenomics through One Codex.
    Full story
  • Adaptive Computing Launches High Productivity Remote Visualization

    Feb 29, 2016, 15:11 PM by Michael Croft
    PROVO, UT, US - Feb 29, 2016 - Adaptive Computing, provider of award-winning workload and resource orchestration software, announces it has integrated Remote Visualization with Moab’s workload submission portal, Viewpoint, in order to improve ease-of-use and increase user productivity
    Full story
  • New CRISPR-Like Defense System Discovered in Giant Viruses

    Feb 29, 2016, 13:05 PM by Michael Croft
    The Atlantic | The bizarre Mimivirus has become even more perplexing, as scientists uncover a genetic element called MIMIVRE, highly analogous to CRISPR, that it uses to fight off smaller viruses.
    Full story
  • «
  • 351
  • 352
  • 353
  • 354
  • 355
  • 356
  • 357
  • 358 (current)
  • 359
  • 360
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy